155 related articles for article (PubMed ID: 22909172)
1. Theophylline is able to partially revert cachexia in tumour-bearing rats.
Olivan M; Springer J; Busquets S; Tschirner A; Figueras M; Toledo M; Fontes-Oliveira C; Genovese MI; Ventura da Silva P; Sette A; López-Soriano FJ; Anker S; Argilés JM
Nutr Metab (Lond); 2012 Aug; 9(1):76. PubMed ID: 22909172
[TBL] [Abstract][Full Text] [Related]
2. Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Olivan M; Busquets S; Figueras M; Fontes de Oliveira C; Toledo M; Sette A; Ventura da Silva P; Barberis P; Argilés JM; López-Soriano FJ
Clin Nutr; 2011 Feb; 30(1):33-7. PubMed ID: 20655130
[TBL] [Abstract][Full Text] [Related]
3. Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats.
Busquets S; Pérez-Peiró M; Salazar-Degracia A; Argilés JM; Serpe R; Rojano-Toimil A; López-Soriano FJ; Barreiro E
J Cell Physiol; 2020 Jan; 235(1):526-537. PubMed ID: 31241186
[TBL] [Abstract][Full Text] [Related]
4. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
5. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.
Penna F; Bonetto A; Aversa Z; Minero VG; Rossi Fanelli F; Costelli P; Muscaritoli M
J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):345-54. PubMed ID: 27239411
[TBL] [Abstract][Full Text] [Related]
6. Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats.
Costelli P; Bossola M; Muscaritoli M; Grieco G; Bonelli G; Bellantone R; Doglietto GB; Baccino FM; Rossi Fanelli F
Cytokine; 2002 Jul; 19(1):1-5. PubMed ID: 12200106
[TBL] [Abstract][Full Text] [Related]
7. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.
Llovera M; Garcia-Martinez C; Agell N; Lopez-Soriano FJ; Argiles JM
Int J Cancer; 1995 Mar; 61(1):138-41. PubMed ID: 7705927
[TBL] [Abstract][Full Text] [Related]
8. Alanine metabolism in rats bearing the Yoshida AH-130 ascites hepatoma.
García-Martínez C; López-Soriano FJ; Argilés JM
Cancer Lett; 1994 Dec; 87(2):123-30. PubMed ID: 7812930
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats.
Llovera M; García-Martínez C; Agell N; Marzábal M; López-Soriano FJ; Argilés JM
FEBS Lett; 1994 Feb; 338(3):311-8. PubMed ID: 8307200
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130).
Costelli P; Llovera M; Carbó N; García-Martínez C; López-Sorianoq FJ; Argilés JM
Cancer Lett; 1995 Aug; 95(1-2):33-8. PubMed ID: 7656241
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
[TBL] [Abstract][Full Text] [Related]
12. Amino acid uptake in skeletal muscle of rats bearing the Yoshida AH-130 ascites hepatoma.
García-Martínez C; López-Soriano FJ; Argilés JM
Mol Cell Biochem; 1995 Jul; 148(1):17-23. PubMed ID: 7476929
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
Busquets S; Fuster G; Ametller E; Olivan M; Figueras M; Costelli P; Carbó N; Argilés JM; López-Soriano FJ
Clin Nutr; 2007 Apr; 26(2):239-44. PubMed ID: 17261345
[TBL] [Abstract][Full Text] [Related]
14. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
[TBL] [Abstract][Full Text] [Related]
16. Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats.
Oliveira AG; Gomes-Marcondes MC
BMC Cancer; 2016 Jul; 16():418. PubMed ID: 27388367
[TBL] [Abstract][Full Text] [Related]
17. Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.
Busquets S; Toledo M; Sirisi S; Orpí M; Serpe R; Coutinho J; Martínez R; Argilés JM; López-Soriano FJ
Exp Ther Med; 2011 Jul; 2(4):731-735. PubMed ID: 22977567
[TBL] [Abstract][Full Text] [Related]
18. Cachexia induced by Yoshida ascites hepatoma in Wistar rats is not associated with inflammatory response in the spleen or brain.
Cernackova A; Mikova L; Horvathova L; Tillinger A; Mravec B
J Neuroimmunol; 2019 Dec; 337():577068. PubMed ID: 31606594
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
20. A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.
Toledo M; Penna F; Oliva F; Luque M; Betancourt A; Marmonti E; López-Soriano FJ; Argilés JM; Busquets S
J Cachexia Sarcopenia Muscle; 2016 Mar; 7(1):48-59. PubMed ID: 27066318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
